Viral Immunology

Papers
(The TQCC of Viral Immunology is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)
ArticleCitations
Epidemiologic Characteristics of SARS-CoV-2 Omicron BA.5.1.3 Variant and the Protection Provided By Inactivated Vaccination116
CD32 Expression by CD4+ T and CD8+ T Lymphocytes Is Increased in Patients with Chronic Hepatitis B Virus Infection38
Comparison of Achievements in the Implementation of COVID-19 Vaccination in Five Provinces to Establish Herd Immunity in Indonesia in the Perspective of the New Public Service36
Association of the Interleukin 1B-31*C Proinflammatory Allele with the Severity of COVID-19 Patients: A Preliminary Report34
Cellular Immune Responses Against γ-Inactivated Antigen in the Recovered Cases of Kyasanur Forest Disease29
Intracellular Toll-Like Receptors Modulate Adaptive Immune Responses in Head and Neck Cancer29
Call for Papers: Viral Immunology27
Coronavirus Disease 2019 Vaccine Development: An Overview18
Structural Analysis and Epitope Prediction of S2 Domain of SARS-CoV-2, Conservation Analysis Among Major Variants16
Nanoadjuvants Produced by Advanced Nanochelating Technology in the Inactivated-Severe Acute Respiratory Syndrome Coronavirus-2 Vaccine Formulation: Preliminary Results on Cytokines and IgG Responses16
Call for Special Issue Papers: Virus-Induced Programmed Cell Death13
Enhanced Programmed Cell Death Protein 1/Programmed Cell Death Ligand 1 Expression Induced by Severe Influenza A Virus Infection Impairs Host's Antiviral Response13
Call for Special Issue Papers: Virus-Induced Programmed Cell Death12
Inflammatory Consequences and Immune Modulation12
Prevalence and Influence of the −174 G/C Polymorphism in the Interleukin-6 Gene in Arboviruses Infections11
Evaluation of an Immunoglobulin E Capture Enzyme-Linked Immunosorbent Assay for the Early Diagnosis of Dengue11
Modulation of Memory B Cell Phenotypes and Toll-Like Receptor-7 in Chronic Hepatitis C Virus Infection During Direct-Acting Antiviral Interferon-Free Therapy: Correlation with Interleukin-711
Epidemiology of Porcine Pseudorabies from 2010 to 2018 in Tianjin, China10
Toll-Like Receptors 7/8: A Paradigm for the Manipulation of Immunologic Reactions for Immunotherapy10
Enhanced Humoral and Cellular Immune Responses Elicited by Salmonella Flagellin-Adjuvanted SARS-CoV-2 S1 Subunit Vaccine8
Increased Peripheral Interleukin-35 Suppresses CD4+ T and CD8+ T-Cell Activity in Patients Living with Chronic Human Immunodeficiency Virus-1 Infection8
Letter to the Editor: The Clinical Features of SARS-CoV-2 Infection Are Becoming Milder with Limited Symptomatic Effects8
Expression Pattern of Inflammatory and Anti-Inflammatory Cytokines and Key Differential Transcription Factors in Peripheral Blood Mononuclear Cells of Iranian Coronavirus Disease 2019 Patients with Di7
Dynamics of SARS-CoV-2-Specific B Cell Memory Responses in Infected and Vaccinated Individuals7
Characteristics of Circulatory γδ T cells in Patients with Symptomatic Chronic Hepatitis B Infection7
The Genetic Variant TNFA (rs361525) Is Associated with Increased Susceptibility to Developing Dengue Symptoms7
Re: “Postinfectious Immunity After COVID-19 and Vaccination Against SARS-CoV-2” by Krsak et al.7
Cells Stimulated with More Than One Toll-Like Receptor–Ligand in the Presence of a MyD88 Inhibitor Augmented Interferon-β via MyD88-Independent Signaling Pathway6
Characterization of Pre-Existing Neutralizing Antibody to Human Adenovirus Types 5 and 49 and Simian Type 23 in Chinese Population6
Formulation of Recombinant H1N1 Hemagglutinin in MF59 and Alum Adjuvants: A Comparison of the Vaccines Potency and Efficacy in BALB/C Mice6
Interleukin-18 Plays a Positive Feedback Activity to Natural Killer-Like B Cells in Hepatitis B Virus-Associated Acute-on-Chronic Liver Failure6
Is There a Rationale for Using Bacillus Calmette–Guerin Vaccine in Coronavirus Infection?6
Investigating the Immunogenic Properties of a Mutagenized NS3/4A-Based HCV Genotype 3a DNA Vaccine6
Relationship Between Human FCγRIIA rs1801274 G Allele and Risk of Death Among Different SARS-CoV-2 Variants6
Adjuvant Effects ofPseudomonas aeruginosaFlagellin on the Immunological Patterns of the HIV-1 Vaccine Candidate: Vaccine Formulations Versus Different Routes of Immunization6
Inhibition of Autophagy Does Not Affect Innate Cytokine Production in Human Lung Epithelial Cells During Respiratory Syncytial Virus Infection6
TLR9 in the Human Papilloma Virus Infections: Friend or Foe?6
The Effect of SARS-CoV-2 on the Spleen and T Lymphocytes6
Does COVID-19 Vaccination with BNT162b2 Influence HIV-Related Immunological and Virological Markers? Data from 235 Persons Living with HIV at Cotugno Hospital, Naples, Italy: Immune Response After Sec6
Functional Single-Nucleotide Polymorphisms in the MBL2 and TLR3 Genes Influence Disease Severity in Influenza A (H1N1)pdm09 Virus-Infected Patients from Maharashtra, India6
Unleash the mRNA6
Dual Roles of Tumor Necrosis Factor Superfamily 14 in Antiviral Immunity6
Virus Protein-Specific Immune Responses in Selective Depletion of Lymphocyte Populations Using Monoclonal Antibodies in Bolivian Squirrel Monkeys (Saimiri boliviensis boliviensisv)6
Assessment of Proinflammatory Cytokines Among Patients with Middle East Respiratory Syndrome Coronavirus Infection6
Elevated Plasma Fractalkine Level Is Associated with the Severity of Hemorrhagic Fever with Renal Syndrome in Humans5
Effect of Disease-Modifying Therapies on COVID-19 Vaccination Efficacy in Multiple Sclerosis Patients: A Comprehensive Review5
Dengue Virus and Platelets: From the Biology to the Clinic5
Diagnostic Value of Natural Killer Cells, CD56+ CD16+ Natural Killer Cells, NLRP3, and Lactate Dehydrogenase in Severe/Critical COVID-19: A Prospective Longitudinal Study According to the Sever5
Immunity in the Presence of Chronic or Repeated Infection5
Hepatitis B Virus Infection Promotes M2 Polarization of Macrophages by Upregulating the Expression of B7x In Vivo and In Vitro5
Advances in the Epidemiology, Pathogenesis, Diagnostic Methods, and Vaccine Development of Dengue Fever: A Comprehensive Review5
The Impact of Vaccination on the Likelihood of COVID-19 Infection5
Epstein-Barr Virus Antibodies and Autoimmune Diseases: A Bidirectional Mendelian Randomization Analysis5
Interleukin-4 Promotes Human Metapneumovirus Replication Through the JAK/STAT6 Pathway5
COVID-19 Infection: Data Gaps for Diagnostic Laboratory Preparedness and Tasks on Hand5
Bioinformation Analysis of Differential Expression Proteins in Different Processes of COVID-195
Comments on Thrombosis After Vaccination: The Leader Sequence of the Spike Protein Might Be Responsible for Thrombosis and Antibody-Mediated Thrombocytopenia5
IGH Complementarity Determining Region-3-Cytomegalovirus Protein Chemical Complementarity Linked to Better Overall Survival Probabilities for Glioblastoma5
Occurrence and Associated Risk Factors of Porcine Reproductive and Respiratory Syndrome Virus and Porcine Circovirus Type 2 Infections in Greece5
Correlation Between TWEAK Serum Level and HTLV-1 Proviral Load in HAM/TSP5
The Age-Dependent Role of Th22, Tc22, and Tc17 Cells in the Severity of Pneumonia in COVID-19 Immunopathogenesis5
Hybrid Immunity Against Severe Acute Respiratory Syndrome Coronavirus 25
Intrinsic and Extrinsic Cell Apoptotic Pathways in Patients with HTLV-1-Associated Myelopathy/Tropical Spastic Paraparesis: A Systematic Review5
The Role of Type I Interferon Signaling in Regulating Cytokine Production and Cell Survival in Bone Marrow-Derived Macrophages4
Let Us Not Forget the Cells4
Interferon-Induced Transmembrane Protein-3 Rs12252-G Variant Increases COVID-19 Mortality Potential in Egyptian Population4
D614G SARS-CoV-2 Pseudovirus Infectivity and Binding of Spike Protein to the ACE2 Receptor Inversely Correlates with Serum SARS-CoV-2-Specific IgG Levels4
Quantitative Antibody Levels Against SARS-CoV-2 Spike Protein in COVID-19 and Multisystem Inflammatory Syndrome in Children4
Acknowledgment of Reviewers 20214
Correction to: A Seroprevalence Study on Residents in a Senior Care Facility with Breakthrough SARS-CoV-2 Omicron Infection, by Kim, et al. Viral Immunology 2023;36(3):203–208; doi: 10.1089/vi4
Anatomical Distribution of Myeloid-Derived Suppressor Cells During HIV Infection4
Maintenance of Long-Term Effective Humoral Immune Response in Patients with COVID-19 with Homologous or Heterologous Booster Vaccines: A Retrospective Study4
An Interview with an Icon: Dr. Anthony Fauci4
Levamisole Therapy in COVID-194
Plasma Levels of Secreted Cytokines in Virologically Controlled HIV-Infected Aging Adult Individuals on Long-Term Antiretroviral Therapy4
Assessment of S-Specific IgG and IgM Positive Rates in Healthy Hospital Staff Members Vaccinated with the Inactivated SARS-CoV-2 Vaccine4
Zika Virus Vaccine: The Current State of Affairs and Challenges Posed by Antibody-Dependent Enhancement Reaction4
Scavenger Receptors in the Pathogenesis of Viral Infections4
SARS-CoV-2-Specific Memory B Cell Responses Are Maintained After Recovery from Natural Infection and Postvaccination3
Interleukin-33 Reinvigorates Antiviral Function of Viral-Specific CD8+ T Cells in Chronic Hepatitis B Virus Infection3
Hepatitis C Virus Alters Macrophage Cholesterol Metabolism Through Interaction with Scavenger Receptors3
Pathogenesis of Coronaviruses Through Human Monocytes and Tissue Macrophages3
SARS-CoV-2 and Guillain–Barré Syndrome: Lessons from Viral Infections3
Expression of SARS-CoV-2 Host Cell Entry Factors in Immune System Components of Healthy Individuals and Its Relevance for COVID-19 Immunopathology3
Interleukin-36gamma Mediates the In Vitro Activation of CD8+ T Cells from Patients Living with Chronic Human Immunodeficiency Virus-1 Infection3
Investigation of SARS-CoV-2 IgG Binding Capability to Variants of the SARS-CoV-2 Virus3
How to Understand Herd Immunity in the Context of COVID-193
Genetic Association of Interleukin-6 Polymorphism (rs1800796) with Chronic Hepatitis B Virus Infection in Chinese Han Population3
Research Progress on the Weak Immune Response to the COVID-19 Vaccine in Patients with Type 2 Diabetes3
Differential Antibody Response to SARS-CoV-2 Antigens in Recovered and Deceased Iranian COVID-19 Patients3
Letter to the Editor: Toll-Like Receptor Antagonists as a Potential Therapeutic Strategy Against Cytokine Storm in COVID-19-Infected Patients3
Letter to the Editor: CD14+HLA-DR+ Cells in Patients May Be a Biomarker Reflecting the Progression of COVID-193
Letter to the Editor: Proposal for Th1-Induction Therapy for Atopic Dermatitis: A Possibility for the Use of the Varicella Zoster Virus Vaccine3
Evaluation of Adjuvant Effect of Cytosine-Guanosine-Oligodeoxynucleotide in Meat-Type Chickens Coadministered In Ovo with Herpesvirus of Turkey Vaccine3
Human Endogenous Retroviruses and Toll-Like Receptors3
Immunogenicity of a Candidate Live Attenuated Vaccine for Rift Valley Fever Virus with a Two-Segmented Genome3
Letter to the Editor: Issues on COVID-19 Pathogenesis3
Transcriptomic Analysis of Interferon Response in Toll-Like Receptor 2 Ligand-Treated and Herpes Simplex Virus 1-Infected Neurons and Astrocytes3
Expression and Clinical Significance of Peripheral Blood IL-17A, IL-22, Tim-3, and gal-9 in Children with Infectious Mononucleosis3
Peripheral Circulating Exosomal-miRNAs Potentially Mediate the Sensitivity to Interferon Treatment in Chronic Hepatitis B Virus Patients3
Letter to the Editor: Should Viruses Exist? A Brief Reflection on the (Re)evolution of the Virus–Life Relationship3
0.33907008171082